Browsing: Firstever

SPRING HOUSE, Pa., Aug. 24, 2026 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced the U.S. Food and Drug Administration (FDA) approval of IMAAVY® (nipocalimab-aahu) for the treatment of warm autoimmune hemolytic anemia (wAIHA) – a rare, life-threatening autoantibody disease – in adults and pediatric patients 12 years of age and older currently or previously…

Combat Power: more than 3,500 service members from 10 countries including Albania, Croatia, Georgia, Italy, Kosovo, Montenegro, Portugal, Romania, Slovenia, and the United States partnered for Exercise Combat Power 26, from June 22 through July 1, 2026, the multinational exercise strengthened interoperability through planning and executing high-intensity joint operations in land, sea, and air domains…